HCPCS drug code · CMS crosswalk
Bortezomib J-Code / HCPCS Code
In short
CMS assigns Bortezomib NDCs to 2 HCPCS codes: J9041 (per 0.1 mg), J9049 (per 0.1 mg). Which one applies depends on the product; the table lists each NDC with its code.
Reference
- J9041
- Injection, bortezomib, 0.1 mgBilling unit: 0.1 mg
- J9049
- Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mgBilling unit: 0.1 mg
- Labelers
- Apotex Corp; Athenex Pharmaceutical Division, LLC; Baxter Healthcare Corporation; BluePoint Laboratories; Dr. Reddy's Laboratories Inc.; Eugia US LLC; FreseniUS Kabi USA, LLC; Hikma Pharmaceuticals USA Inc.and 8 more
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Bortezomib units and claim line
Enter the dose given to get the J9041 units and the NDC line for the CMS-1500 and the 837P. This builds the J9041 line; use the code page for J9049.
Enter the dose given to build the claim line.
Bortezomib NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00143-9098-01 | J9041 | Hikma Pharmaceuticals USA Inc. | 1 | 35 |
| 00409-1700-01 | J9041 | Pfizer Inc | 1 | 35 |
| 10019-0991-01 | J9041 | Baxter Healthcare Corporation | 1 | 35 |
| 25021-0244-10 | J9041 | Sagent Pharmaceuticals | 1 | 35 |
| 25021-0262-10 | J9041 | Sagent Pharmaceuticals | 1 | 35 |
| 43598-0426-60 | J9041 | Dr. Reddy's Laboratories Inc. | 1 | 35 |
| 50742-0484-01 | J9041 | Ingenus Pharmaceuticals LLC | 1 | 35 |
| 55150-0337-01 | J9041 | Eugia US LLC | 1 | 35 |
| 60505-6050-04 | J9041 | Apotex Corp | 1 | 35 |
| 63323-0821-10 | J9041 | FreseniUS Kabi USA, LLC | 1 | 35 |
| 68001-0534-36 | J9041 | BluePoint Laboratories | 1 | 35 |
| 68001-0540-36 | J9041 | BluePoint Laboratories | 1 | 35 |
| 68001-0541-36 | J9041 | BluePoint Laboratories | 1 | 35 |
| 70069-0836-01 | J9041 | Somerset Pharma, LLC | 1 | 35 |
| 70710-1411-01 | J9041 | Zydus Pharmaceuticals (USA) Inc. | 1 | 35 |
| 70860-0225-10 | J9041 | Athenex Pharmaceutical Division, LLC | 1 | 35 |
| 71288-0118-10 | J9041 | Meitheal Pharmaceuticals Inc. | 1 | 35 |
| 72205-0183-01 | J9041 | Novadoz Pharmaceuticals LLC | 1 | 35 |
| 72603-0270-01 | J9041 | Northstar RxLLC | 1 | 35 |
| 00409-1703-01 | J9049 | Pfizer Inc | 1 | 25 |
| 00409-1704-01 | J9049 | Pfizer Inc | 1 | 10 |
Bortezomib: common questions
- What is the J-code for Bortezomib?
- CMS assigns Bortezomib NDCs to 2 HCPCS codes: J9041 (per 0.1 mg), J9049 (per 0.1 mg). Which one applies depends on the product; the table lists each NDC with its code.
- How many J9041 billing units are in a package of Bortezomib?
- CMS lists 35 billing units per package, depending on the NDC, where one unit is 0.1 mg. Units to report are based on the dose given, not the package.
- How many J9049 billing units are in a package of Bortezomib?
- CMS lists 10 to 25 billing units per package, depending on the NDC, where one unit is 0.1 mg. Units to report are based on the dose given, not the package.
- Is J9041 a CPT code?
- No. J9041 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.
Other codes for the same drug
- J9046Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg
- J9048Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
- J9051Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
- J9054Injection, bortezomib (boruzu), 0.1 mg